Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization

Launched by UNIVERSITY OF KANSAS MEDICAL CENTER · Jan 3, 2019

Keywords

ClinConnect Summary

This clinical trial is studying how effective a treatment called gonadal vein embolization is for relieving pelvic pain caused by a condition known as Pelvic Congestion Syndrome (PCS). The goal is to measure how much pain relief patients experience after the procedure and to find out if certain factors, like medical history or imaging results, can predict how well someone might respond to the treatment.

To be eligible for this trial, participants must be women aged 18 or older who have been diagnosed with PCS and meet specific medical imaging criteria. They should not have any conditions that could interfere with the treatment, such as certain types of vascular problems or previous surgeries that affect the gonadal veins. If you join this trial, you can expect to undergo the embolization procedure in a specialized area of the hospital and be monitored afterward to see how well the treatment works for you.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Female patients 18 years of age or older
• • Meet the clinical and imaging criteria for the diagnosis of PCS and have no contraindications to coil embolization of the gonadal veins.
• • Patients who are treated with coil embolization of the gonadal veins in the Interventional Radiology division between October 1, 2018 to October 1, 2019.
• Exclusion Criteria:
• • Patients less than 18 years of age.
• • Patients who are found to have an underlying cause of pelvic congestion syndrome unrelated to venous congestion and insufficiency. This includes, but is not limited to, nutcracker syndrome, or a mass resulting in extrinsic compression of the gonadal veins.
• • Patients who have received prior surgical therapy for PCS, including bilateral salpingo-oophorectomy (TAH-BSO), gonadal vein resection, or gonadal vein ligation.